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ABSTRACT
Rab coupling protein (RCP) is a Rab GTPase effector that functions in endosomal 
recycling. The RCP gene is frequently amplified in breast cancer, leading to increased 
cancer aggressiveness. Furthermore, RCP enhances the motility of ovarian cancer 
cells by coordinating the recycling of α5β1 integrin and EGF receptor to the leading 
edge of migrating cells. Here we report that RCP also influences the motility of lung 
adenocarcinoma cells. Knockdown of RCP inhibits the motility of A549 cells in 2D and 3D 
migration assays, while its overexpression enhances migration in these assays. Depletion 
of RCP leads to a reduction in N-cadherin protein levels, which could be restored with 
lysosomal inhibitors. Trafficking assays revealed that RCP knockdown inhibits the 
return of endocytosed N-cadherin to the cell surface. We propose that RCP regulates 
the endosomal recycling of N-cadherin, and in its absence N-cadherin is diverted to the 
degradative pathway. The increased aggressiveness of tumour cells that overexpress 
RCP may be due to biased recycling of N-cadherin in metastatic cancer cells.
INTRODUCTION
The endosomal recycling pathway mediates the 
transport of endocytosed proteins back to the plasma 
membrane, and it is emerging that aberrant expression 
of key regulators of this pathway can lead to increased 
aggressiveness in a wide range of cancers [1, 2]. Rab11 
regulates cargo transport from the endosomal recycling 
compartment (ERC) to the plasma membrane. Rab25, an 
epithelial-specific isoform of the Rab11 subfamily, has been 
reported to act as both an oncogene and tumour suppressor 
gene in various cancers [3]. RCP is a Rab11 effector protein 
encoded by a gene that maps to chromosome 8p11-12, a 
region that is frequently amplified in cancer [4].  RCP has 
been found to be a breast cancer promoting gene and its 
overexpression significantly correlates with aggressive 
breast cancer [5]. Furthermore, RCP mediates the recycling 
of α5β1 integrin and the EGF receptor to the leading edge of 
migrating A2780 ovarian cancer cells [6], and this recycling 
is enhanced by mutant p53 [7].
RCP belongs to a family of proteins whose members 
are characterised by a highly conserved ~20 amino acid 
Rab-binding domain (RBD) at their C-termini that 
mediates their interaction with Rabs. There are five key 
members of this Rab11-Family of Interacting Proteins 
(FIPs), and the FIPs can be subdivided into two classes. 
The class I FIPs possess a C2 domain at their amino 
terminus which preferentially binds to phosphatidic acid 
and PI(3, 4, 5)P3 at the plasma membrane [8, 9]. The class 
II FIPs lack a C2 domain but possess calcium-binding 
EF-hand motifs. In addition to Rab11, the class I FIPs 
can also bind to Rab14 [10, 11], which localises to early 
endosomes, the endosomal recycling compartment and 
the Golgi [12]. Rab14 has been reported to play a role in 
N-cadherin junctional complex formation by stimulating 
the transport of the ADAM10 metalloproteinase to 
the plasma membrane of A549 lung adenocarcinoma 
cells [13]. ADAM10 cleaves N-cadherin at the plasma 
membrane resulting in the shedding of its ectodomain. 
The Barr group found that depletion of Rab14 trapped 
ADAM10 in an intermediate recycling compartment, 
preventing it reaching the plasma membrane and leading 
to a dramatic increase of full-length N-cadherin at the cell 
surface. Rab14 and RCP have recently been implicated 
in the trafficking of the HIV-1 Env glycoprotein to the 
plasma membrane in infected cells [14].
Given the previously described role for RCP in 
promoting the migration of breast and ovarian cancer 
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cells, and the fact that the 8p11-12 amplicon has been 
frequently observed in other cancers [15–18], we decided 
to investigate whether RCP has a similar role in non-
small cell lung cancer (NSCLC) cells. Lung cancer is 
highly aggressive and is the leading cause of cancer 
deaths worldwide, with an overall 5-year survival rate of 
less than 13%. We found that RCP knockdown resulted 
in a reduction in the motility of A549 cells, whereas 
overexpression of wild-type RCP led to increased motility. 
RCP knockdown resulted in a loss of polarisation of the 
Golgi complex and a reduction in the levels of N-cadherin 
protein. Trafficking assays demonstrated that RCP plays an 
important role in the recycling of endocytosed N-cadherin 
to the cell surface. Treatment of RCP-depleted cells with 
lysosomal inhibitors restored N-cadherin levels suggesting 
that in the absence of RCP, internalised N-cadherin is 
diverted to the degradative pathway where it is degraded 
in lysosomes.
RESULTS
RCP is required for the migration of non-small 
cell lung cancer cells
To investigate if RCP serves a role in the migration 
of NSCLC cells, A549 cells were transfected with a 
control siRNA, that is complementary to the Firefly 
luciferase mRNA (siFLuc), or two separate siRNA 
duplexes that target RCP (siRCP#3 and siRCP#4). 
72 hours post-transfection, when the cells have reached 
confluency, they were scratched with a plastic pipette 
tip and returned to 37oC. After 18 hours the distance that 
the cells had migrated into the wound was measured. We 
typically achieved ~ 90% knockdown of RCP under these 
conditions (Supplementary Figure S1A, S1B). A549 cells 
transfected with siRCP#4 displayed a 40% reduction of 
migration into the wound (Figure 1A). However, siRCP#3 
had no significant effect (Figure 1A).
Given the inconclusive results obtained from the 
scratch-wound assays, and previous observations that 
Rab25 influences cell motility in 3D migration assays but 
not in 2D assays [19], we proceeded to investigate whether 
RCP depletion affected the motility of A549 cells in 3D 
migration assays. We used a real-time impedance-based 
assay (xCelligence) to monitor the migration of cells 
through a semipermeable membrane containing 8 μm 
pores. In this migration assay, both RCP targeting siRNA 
duplexes significantly inhibited the migration of the 
transfected cells (Figure 1B). Inhibition was also observed 
in invasion assays in which the transfected cells were 
seeded on top of a layer of Matrigel and the cells had to 
penetrate through this reconstituted basement membrane 
before they reach the semipermeable barrier (Figure 1C). 
We next set out to investigate the effect of RCP 
overexpression in these cell motility assays. To this 
end, A549 cell lines stably transfected with plasmids 
expressing green-fluorescent protein (GFP) alone, GFP 
fused wild-type RCP (GFP-RCPWT), or a mutant of 
RCP with a single amino acid change in its RBD that 
abolishes the interaction with Rab11 and Rab14 (GFP-
RCPI621E) [11], were generated. Expression of the fusion 
protein is induced by supplementing the growth medium 
with sodium butyrate 24 hours prior to the experiment 
(Supplementary Figure S1C, S1D). Quantification 
revealed that 5mM sodium butyrate induced levels 
of GFP-RCPWT and GFP-RCPI621E expression of 3.1 ± 
0.02 and 2.5 ± 0.14 fold over that of endogenous RCP, 
respectively (Supplementary Figure S1E). Overexpression 
of wild-type RCP increased the motility of A549 cells in 
the scratch-wound (Figure 2A), migration (Figure 2B), 
and invasion assays (Figure 2C), whereas the cell line 
expressing RCPI621E migrated at the same rate as the control 
cells expressing GFP alone (Figure 2A–2C). To determine 
if the reduction in cell motility observed upon siRNA-
mediated depletion of endogenous RCP could be rescued 
by overexpression of GFP-RCP, we transfected the stable 
cell lines with an siRNA that targeted the 5′ untranslated 
region of RCP (siRCP#5). Induction of GFP-RCPWT, 
but not GFP-RCPI621E, in cells transfected with siRCP#5 
rescued the inhibitory effect, in both wound healing and 
cell migration assays (Supplementary Figure S2A, S2B). 
This rules out the possibility that the suppression of cell 
motility observed when RCP is downregulated is due to 
off-target effects of the siRNA complexes.
Taken together, these results demonstrate that RCP 
plays an important role in regulating the migration of 
A549 lung adenocarcinoma cells, and agrees with similar 
findings in breast and ovarian cancer cells [5, 6].
To investigate if defective polarisation of RCP-
depleted cells may account for the inhibition in migration, 
monolayers of A549 cells transfected with control and RCP 
siRNA duplexes were wounded and allowed to recover for 
5 hours. The localisation of the Golgi complex in cells 
at the wound edge was determined by immunofluorescent 
labelling of the GM130 cis-Golgi marker. Cells orient 
their Golgi to face the direction of migration in wounded 
cells [20], and in ~ 80% of control cells the Golgi complex 
was oriented in front of the nucleus facing the wound edge 
(Figure 2D, 2E). In contrast, depletion of RCP resulted in 
a considerable reduction in the proportion of cells with 
wound-oriented Golgi complexes (siRCP#3 = 53.5 ± 
5.0%; siRCP#4 = 32.6 ± 3.8%), indicating that an inability 
to establish an axis of polarity with respect to the wound 
edge may contribute to the migration defects.
RCP regulates cadherin protein levels
Rab14 was recently found to play a role in 
controlling N-cadherin protein levels, by regulating the 
transport of the ADAM10 metalloproteinase to the plasma 
membrane where it cleaves N-cadherin [13]. Given that 
Rab14 interacts with RCP, and N-cadherin has been 
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found to promote the motility and invasion of tumour cell 
lines [21–23], we investigated whether RCP knockdown 
could also affect N-cadherin protein levels. We observed 
a striking reduction in the amount of N-cadherin at the 
plasma membrane by immunofluorescence (Figure 3A), 
and quantification by Western blot revealed an 
approximately 50% reduction in total N-cadherin protein 
levels in RCP-depleted cells (Figure 3B, 3C). Rab11 has 
a well characterised role in the trafficking of E-cadherin 
[24, 25]; therefore we investigated whether E-cadherin 
levels were also reduced under the same conditions. 
Surprisingly, we found that transfection with RCP siRNA 
resulted in an increase of E-cadherin levels relative to 
siFLuc transfected cells, or a non-transfected control 
(Figure 3B, 3C).
A greater than 80% increase in N-cadherin protein 
levels was observed in the GFP-RCPWT stable cell line 
treated with 5mM sodium butyrate for 24 hours (to 
induce expression of the fusion protein), but there was 
no such increase in the GFP, and GFP-RCPI621E cell lines 
(Figure 3D, 3E). E-cadherin levels were not significantly 
altered in all of these cell lines. The RCP gene is frequently 
amplified in cancer (Supplementary Figure S3A), 
and analysis of data from the TCGA collective Lung 
Squamous Cell Carcinoma panel (TCGA, provisional) 
revealed that the expression of N-cadherin protein is 
elevated in tumours in which the RCP gene is amplified 
(Supplementary Figure S3B), which is in agreement with 
our in vitro data.
E-cadherin and N-cadherin are important factors 
in the invasion and growth of epithelial cancer cells, 
with E-cadherin acting as a ‘brake’ on invasion while 
N-cadherin promotes invasion and metastasis [26, 27]. 
Thus, the effect of altering the expression of RCP 
on the motility of A549 cells is likely to be due to the 
concomitant change in the levels of E- and N- cadherin. 
To investigate whether the enhanced motility of A549 
cells expressing GFP-RCPWT may be due to the increased 
level of N-cadherin in these cells, we performed 
wound healing assays in the presence or absence of the 
N-cadherin inhibitor Exherin (ADH-1). Exherin is a cyclic 
pentapeptide that acts as a specific N-cadherin antagonist 
[28]. Addition of Exherin to the culture medium in normal 
wounded A549 cells leads to a dose-dependent delay in the 
Figure 1: Downregulation of RCP inhibits cell motility. (A) A549 cells in 24-well plates were transfected with a control siRNA 
or two siRNA duplexes targeting RCP. 72 hours post-transfection the cell monolayers were wounded and brightfield images recorded. The 
cells were returned to 37oC for 18 hours and imaged again. The distance migrated by the wound front is plotted in the bar graph. Error bars 
indicate the standard error of the means (*p < 0.05; n = 3). (B) A549 cells were transfected with the indicated siRNA duplexes for 72 hours, 
detached and seeded in duplicate on CIM-16 Transwell plates and subjected to real-time migration assays (xCelligence). The histogram 
depicts the Normalised Cell Index (CI) after 24 hours of migration. Error bars indicate the standard error of the means (*p < 0.05, ***p < 0.001; 
n = 4). (C) A549 cells transfected with the indicated siRNA duplexes for 72 hours, were detached and seeded, in duplicate, on CIM-16 
Transwell plates that had been coated with Matrigel. The histogram depicts the Normalised Cell Index (CI) after 48 hours of migration. 
Error bars indicate the standard error of the means (**p < 0.01, ***p < 0.001; n = 3). 
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Figure 2: Overexpression of RCP promotes cell motility. (A) Monolayers of A549 cells induced to express GFP, GFP-RCPWT, 
or GFP-RCPI621E for 24 hours were wounded and bright-field images recorded. The cells were returned to 37
oC for 18 hours and imaged 
again. The distance migrated by the wound front is plotted in the bar graph. Error bars indicate the standard error of the means (*p < 0.05, 
n = 3). (B) A549 cells expressing the indicated GFP-fusion constructs were seeded, in duplicate, on CIM-16 Transwell plates. The histogram 
depicts the Normalised Cell Index (CI) after 24 hours of migration. Error bars indicate the standard error of the means (**p < 0.01; n = 3). 
(C) A549 cells expressing the indicated GFP-fusion constructs were seeded, in duplicate, on CIM-16 Transwell plates that had been coated 
with Matrigel. The histogram depicts the Normalised Cell Index (CI) after 48 hours of migration. Error bars indicate the standard error of 
the means (*p < 0.05; n = 5). (D–E) A549 cells transfected with the indicated siRNA duplexes for 72 hours, were wounded and allowed to 
recover at 37oC for 5 hours. The cells were fixed and labelled with DAPI (blue), anti-Texas Red-phalloidin (red), and the Golgi complex 
was labelled with anti-GM130 (green). Bar, 10 μm (D). The localisation of the Golgi in > 100 cells, from 3 independent experiments, is 
depicted in the bar graph (E).
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closure of the wound (Figure 3F), and Exherin suppressed 
the enhanced migration of the GFP-RCPWT -overexpressing 
A549 cells (Figure 3G). This result confirms that the 
higher level of N-cadherin in these cells is an important 
factor contributing to their increased motility.
The dissemination of metastatic cancer cells 
requires the degradation of basement membrane, adhesion 
to endothelial cells of the vasculature, retraction of 
endothelial junctions, and finally invasion of the tumour 
cell into the blood stream in order to spread to distant 
sites in the host. Once in the circulation, cancer cells 
can then adhere to capillary walls and extravasate into 
the surrounding tissue to form metastatic tumours [29]. 
N-cadherin is expressed on the surface of endothelial 
cells and during intravasation it is thought to act as 
a receptor for the attachment of cancer cells that are 
overexpressing N-cadherin. To further measure the role 
that RCP plays in cell invasiveness, the effect of A549 
cells on the permeability of a barrier of endothelial cells 
was monitored. Human umbilical vein endothelial cells 
(HUVECs) were seeded onto gold electrodes that line the 
bottom surface of a microplate attached to the xCelligence 
instrument. This allows the real-time monitoring of 
changes of electrical resistance as a cell monolayer, with 
intact cell-cell junctions, forms. The impedance values are 
translated into cell indexes (CI) that increase over time 
until they reach a plateau, indicating that a tight junctional 
barrier has been obtained. The CI values for HUVEC 
cells typically reach a plateau after 19–21 hours. At this 
point A549 cells, that had been transfected for 72 hours 
with control or RCP siRNA, are added to the HUVEC 
monolayer and CI is monitored for a further 7 hours. 
Disruption of the barrier integrity due to the retraction of 
the endothelial junctions by the tumour cells leads to a 
decrease in the CI. A549 cells depleted of RCP were less 
efficient at disrupting the integrity of endothelial junctions, 
as indicated by a higher cell index for the HUVEC 
monolayer seeded for 7 hours with A549 cells transfected 
with siRNAs targeting RCP (siRCP#3 CI = +16 ± 2.9%; 
siRCP#4 CI = +19.2 ± 5.2%) (Figure 3H). The A549 
cells stably overexpressing GFP-RCPWT did not promote 
increased endothelial junction disruption when compared 
to cells expressing GFP alone, however the GFP-RCPI621E 
cells displayed ~ 10% inhibition in disruption of junctional 
integrity (Figure 3I). 
Depletion of RCP disrupts the cadherin switch 
during epithelial-mesenchymal transition
The ratio of E-cadherin to N-cadherin is important 
to the process of epithelial-mesenchymal transition 
(EMT), the trans-differentiation of epithelial cells 
into motile mesenchymal cells. A hallmark of EMT 
is the downregulation of E-cadherin, leading to the 
destabilisation of adherens junctions, and a corresponding 
increase in expression of N-cadherin. This ‘cadherin 
switch’ facilitates cell migration and invasion [30]. A549 
cells can be induced to undergo EMT by treatment with 
recombinant human TGFβ1 ligand for 48 hours, however 
RCP knockdown dampens the cadherin switch (i.e. 
N-cadherin protein level/E-cadherin protein level) by 2.5- 
to 6- fold under these conditions (Figure 4A, 4B). EMT 
is accompanied by the up- or down- regulation of various 
transcription factors, cytoskeletal proteins, signalling 
proteins and miRNA species. We looked at a number 
of these and found that there were elevated levels of 
β-catenin when RCP was knocked down (Supplementary 
Figure S4E), but no effect on the TWIST and TCF4 
transcription factors (Supplementary Figure S4D, S4F). 
The intermediate filament proteins cytokeratin 19 and 
vimentin are down- and up- regulated, respectively, during 
EMT. We detected no difference in vimentin levels when 
RCP was depleted (not shown), however the level of 
cytokeratin 19 was higher in the RCP-knockdown cells 
when compared to controls (Figure 4C). These results 
suggest that RCP knockdown maintains A549 cells in an 
‘epithelial-like’ state by affecting the levels of a subset of 
EMT markers.
EMT is also accompanied by a morphological 
change, and comparison of sodium butyrate treated 
and untreated GFP-RCPWT stable cells by fluorescence 
microscopy revealed that the untreated cells, in 
which RCPWT is not overexpressed, maintained their 
‘cobblestone’ appearance characteristic of epithelial cells. 
In contrast, induction of GFP-RCPWT led to the cells 
adopting a more mesenchymal morphology i.e. the cells 
had lost defined cell-cell contacts, became more elongated, 
and developed prominent stress fibres (Figure 4D), 
indicating that upregulation of RCP expression is sufficient 
to induce the cells to adopt a mesenchymal morphology. 
RCP regulates the recycling of N-cadherin
The reduction in N-cadherin levels upon RCP 
downregulation may be due to one of a number of 
factors; (i) RCP knockdown affects N-cadherin mRNA 
transcription, (ii) RCP knockdown leads to increased 
N-cadherin shedding at the plasma membrane, (iii) 
RCP knockdown promotes proteasomal degradation 
of N-cadherin, or (iv) RCP knockdown promotes the 
lysosomal degradation of N-cadherin. 
Quantitative RT-PCR revealed that RCP depletion 
did not consistently affect the levels of N-cadherin 
mRNA (Supplementary Figure S4A, S4B), ruling out the 
possibility that RCP regulates N-cadherin expression at 
the transcriptional level. Moreover, while lung squamous 
cell tumours in which the RCP gene has been amplified 
show increased expression of N-cadherin protein 
(Supplementary Figure S3B), the N-cadherin mRNA 
levels are unaffected in these tumours (Supplementary 
Figure S3C). This provides further evidence that RCP does 
not affect N-cadherin gene expression.  E- and N- cadherin 
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Figure 3: RCP regulates cadherin protein levels. (A) A549 cells transfected with the indicated siRNA duplexes for 72 hours, fixed 
and labelled with DAPI and anti-N-cadherin. Bar, 10 μm. (B) A549 cells transfected with the indicated siRNA duplexes were lysed after 
72 hours and Western blotted with the indicated antibodies. α-tubulin was used as a loading control. (C) Histogram represents the level of 
N-cadherin (black) and E-cadherin (white) protein in lysates from cells transfected for 72 hours with the indicated siRNA duplexes. Values 
are normalised to siFLuc (*p < 0.05, **p < 0.01, ***p < 0.001; n = 6). (D) Representative Western blots of lysates from A549 GFP-RCPWT and 
GFP-RCPI621E stable cell lines treated with the indicated concentrations of sodium butyrate for 24 hours. (E) Level of N-cadherin protein 
in lysates from the indicated A549 stable cell lines treated +/– 5 mM sodium butyrate for 24 hours (*p < 0.05; n = 3). (F) A549 cells grown 
to confluency were wounded and allowed to recover for 18 hours at 37oC in the presence of DMSO (vehicle control) or the indicated 
concentration of ADH-1 (Exherin). The distance migrated by the wound front is plotted in the bar graph. Error bars indicate the standard 
error of the means (*p < 0.05, ***p < 0.001; n = 3). (G) A549 or A549 GFP-RCPWT cells were grown to confluency, wounded and allowed 
to recover for 18 hours at 37oC in the presence of DMSO (vehicle control) or the indicated concentration of ADH-1 (Exherin). The cells 
were treated for a total of 24 hours with 5mM sodium butyrate to induce expression of the fusion protein (6 hours pre-wounding and 18 
hours post-wounding). The distance migrated by the wound front is plotted in the bar graph. Error bars indicate the standard error of the 
means (*p < 0.05, **p < 0.01; n = 3). (H) A549 cells transfected with the indicated siRNA duplexes were detached and seeded, in duplicate, 
on top of a monolayer of HUVECs grown in an E-16 plate. The histogram indicates the Normalised Cell Index, normalised to siFLUC, 
7 hours after addition of the A549 cells. Error bars indicate the standard error of the means (*p < 0.05; n = 3). (I) A549 cells expressing the 
indicated GFP-fusion protein were seeded, in duplicate, on top of a monolayer of HUVECs grown in an E-16 plate. The histogram indicates 
the Normalised Cell Index, normalised to GFP, 7 hours after addition of the A549 cells. Error bars indicate the standard error of the means 
(n = 3). 
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Figure 4: RCP knockdown disrupts the cadherin switch during EMT. (A) Representative Western blots of lysates from A549 
cells were transfected with the indicated siRNA duplexes for 24 hours and then treated +/– 5 ng/ml TGFβ1 for a further 48 hours. α-tubulin 
was used as a loading control. (B) Histogram indicating the ratio of E-cadherin to N-cadherin protein in A549 cells transfected with the 
indicated siRNA duplexes for 24 hours and treated +/– 5ng/ml TGFβ1 for a further 48 hours. Values are normalised to siFLuc Control 
(n = 3). (C) Histogram indicating the levels of the cytokeratin 19 intermediate filament protein in A549 cells transfected with the indicated 
siRNA duplexes for 24 hours and treated +/– 5 ng/ml TGFβ1 for a further 48 hours. Values are normalised to siFLuc Control (*p < 0.05, **p 
< 0.01; n = 5). (D) Fluorescence images of the A549 GFP-RCPWT stable cell line treated +/– 5 mM sodium butyrate for 24 hours prior to 
fixation and labelling with Texas Red-phalloidin (red). Bar, 10 µm.
undergo sequential cleavage, or ‘cadherin shedding’ at 
the plasma membrane (Supplementary Figure S5A). 
ADAM10 cleaves the ~ 80 kDa ectodomain of N-cadherin 
resulting in its release into the extracellular medium. The 
C-terminal domain is subsequently cleaved into smaller 
fragments by the sequential action of presenilin-1 and 
caspase-3. If the reduction of full length N-cadherin was 
due to increased proteolysis at the plasma membrane, it 
would be expected that there would be a corresponding 
increase of C-terminal fragments of N-cadherin. However 
no such increase was observed in RCP-depleted cell 
lysates indicating that RCP is not involved in cadherin 
shedding at the plasma membrane (Supplementary 
Figure S5B). Also, treatment of siRNA transfected cells 
with a selective ADAM10 inhibitor, GI254023X, for 
24 hours prior to lysis did not result in a recovery of full-
length N-cadherin levels (Supplementary Figure S5C). 
Furthermore, RCP depletion did not consistently affect 
the overall level of the ADAM10 metalloproteinase, and 
actually resulted in a statistically significant decrease of 
presenilin-1 (Supplementary Figure S5D, S5E). These 
results demonstrate that the siRCP-induced reduction in 
N-cadherin levels is not caused by increased ‘cadherin 
shedding’ at the plasma membrane.
To investigate whether the reduction of N-cadherin 
is due to increased lysosomal or proteasomal degradation, 
siRNA transfected cells were treated for 24 hours with 
NH4Cl, to inhibit lysosomal degradation, or lactacystin, 
a specific proteasomal inhibitor. Under these conditions 
a statistically significant recovery of N-cadherin levels 
was observed in the cells treated with NH4Cl (Figure 5A), 
indicating that RCP knockdown promotes the lysosomal 
degradation of N-cadherin. Lactacystin had no effect on 
N-cadherin (Figure 5A). NH4Cl treatment also led to a 
slight recovery in the migration of siRCP#4-transfected 
cells (Figure 5B). 
These results suggest that RCP is involved in 
the recycling of endocytosed N-cadherin. In RCP-
depleted cells the recycling of internalised N-cadherin 
to the cell surface is suppressed and is instead diverted 
to the degradative pathway where it is broken down in 
lysosomes. To determine if this is the case, we devised 
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a quantitative N-cadherin recycling assay. In this 
assay, monolayers of siRNA transfected A549 cells are 
induced to internalise their adherens junction proteins by 
addition of the calcium chelator, EDTA, into the culture 
medium for 1 hour. The EDTA is washed out, fresh 
medium is added, and cell-cell junctions are allowed 
to reassemble for various times. At each time-point 
the cells are fixed and N-cadherin at the cell surface is 
detected and quantitated with an antibody that recognises 
its ectodomain (Figure 5C). Recycled N-cadherin is 
calculated by normalising cell surface N-cadherin at each 
time point to that at 0 hours (cells fixed immediately after 
EDTA washout). Even though there is a reduced amount of 
N-cadherin in RCP-depleted cells, there is still sufficient 
remaining at the cell surface to monitor its internalisation 
and recycling. We observed a significant inhibition of 
N-cadherin recycling in RCP-depleted cells in comparison 
to control cells (Figure 5D). Taken together, these data 
demonstrate that RCP functions to re-route endocytosed 
N-cadherin away from the degradative pathway and send 
it back to the plasma membrane.
To further investigate if N-cadherin undergoes 
endosomal recycling we made use of the endosomal 
recycling inhibitor, primaquine (PMQ). We found that 
PMQ inhibits wound healing in a dose-dependent manner 
(Figure 6A), and overnight treatment with PMQ leads 
to a reduction in N-cadherin protein levels without 
affecting E-cadherin levels (Figure 6B). In recycling 
assays, in which PMQ was added to the culture medium 
after the EDTA wash-out (Figure 6C), N-cadherin 
recycling was significantly inhibited (Figure 6D, 6E). 
Surprisingly, E-cadherin recycling was increased in the 
presence of PMQ (Figure 6F). These results demonstrate 
that endocytosed N-cadherin is returned to the plasma 
membrane along the endosomal recycling pathway.
Immunofluorescence labelling of non-permeablised 
A549 cells, pre-treated with 300 µM PMQ for 1 hour, 
with an antibody to the N-cadherin ectodomain revealed 
a significant reduction of cell surface N-cadherin in 
comparison to untreated cells (Figure 7A). This indicates 
that N-cadherin is continuously internalised and recycled, 
and PMQ traps the internalised N-cadherin inside the 
cell. PMQ treatment for 1 hour also resulted in a 1.8-fold 
increase in colocalisation between RCP and N-cadherin in 
intracellular vesicles (Figure 7B). 
DISCUSSION
RCP plays a role in the migration of lung 
adenocarcinoma cells
The endosomal recycling pathway mediates the 
return of endocytosed proteins and lipids to the cell 
surface. It is one of the main cellular mechanisms for 
controlling the composition of the plasma membrane. It 
is emerging that aberrant expression of key regulators of 
endosomal recycling can lead to increased aggressiveness 
in a wide range of cancers, presumably due to  downstream 
effects on cell signalling and the biased recycling of 
adhesion molecules, matrix metalloproteinases, and 
receptor tyrosine kinases [1, 2]. One such regulator is RCP, 
a membrane associated protein that binds to Rab GTPases 
of the endosomal recycling pathway (Rabs 4, 11, and 14) 
[10, 11, 31]. The RCP gene is amplified in a wide range of 
cancers [4, 15–18], and its overexpression has been linked 
to increased aggressiveness in breast cancer [5]. 
Furthermore, Caswell et al. have demonstrated that 
RCP drives the transport of α5β1 integrin and the EGF 
receptor to the leading edge of migrating ovarian cancer 
cells [6]. Here we demonstrate that RCP also plays a role 
in the motility and invasion (key features of metastatic 
tumour cells) of lung adenocarcinoma cells. RNAi-
mediated downregulation of RCP led to an inhibition 
in the motility of these cells in cell migration assays. 
Conversely overexpression of wild-type RCP, but not an 
inactive mutant, increased cell motility. Cell migration is a 
critical process for tissue organisation during development 
and its dysregulation can lead to a number of diseases, 
including cancer.
RCP regulates cadherin levels and influences 
epithelial-mesenchymal transition
In order to determine the molecular basis of the 
role of RCP in cell migration, we first examined if RCP 
knockdown affects the polarisation of migrating cells. 
The Golgi apparatus rapidly reorients itself forward of 
the nucleus and facing the leading edge in migrating cells 
[20]. We found that depletion of RCP disrupts this process, 
leading to a more random distribution of the Golgi in 
cells at the wound edge. Furthermore, the Golgi cisternae 
were much less compact in comparison to the control 
cells. Polarisation defects are usually associated with 
more random and less persistent cell migration, however 
analysis of cell trajectories in time-lapse movies of 
migrating cells revealed that RCP knockdown affected the 
velocity, but not the directionality of cells (Supplementary 
Figure S2C–S2E). This suggests that polarity defects 
cannot fully account for the observed inhibition in cell 
motility.
Given the accumulating evidence that Rab4, 
Rab11, and Rab14 are involved in E- and N- cadherin 
trafficking [13, 24, 25, 32, 33], we examined the effect 
of RCP knockdown on the localisation and expression 
of these cadherins. A reduction of N-cadherin protein 
levels was observed in cells depleted of RCP, by both 
immunofluorescence and Western blot. Surprisingly, this 
reduction in N-cadherin was accompanied by an increase 
in E-cadherin levels. In contrast, overexpression of wild-
type RCP led to increased N-cadherin expression without 
affecting E-cadherin levels. E-cadherin and N-cadherin 
are important factors in the invasion and growth of 
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Figure 5: RCP regulates the recycling of endocytosed N-cadherin back to the plasma membrane. (A) Histogram depicting 
the level of full-length N-cadherin protein in A549 cells transfected with the indicated siRNA duplexes for 72 hours and treated with vehicle 
alone, 20 mM NH4Cl, or 10 µM lactacystin for the final 24 hours (
*p < 0.05; n = 3). (B) A549 cells were transfected with siFLuc or siRCP#4 
for 72 hours. The monolayers were wounded and the fresh media was supplemented with or without 20 mM NH4Cl. The distance migrated 
is plotted in the histogram. (C) Timeline of the N-cadherin recycling assay (see Experimental Procedures). (D) N-cadherin recycling assay 
in cells transfected for 72 hours with the indicated siRNA duplexes (*p < 0.05, **p < 0.01; n = 3).
epithelial cancer cells, with E-cadherin acting as a ‘brake’ 
on invasion while N-cadherin promotes invasion and 
metastasis [26, 27]. Indeed, N-cadherin is upregulated 
in the most invasive and de-differentiated breast and 
prostate cancers [34, 35]. An N-cadherin antagonist was 
able to suppress the enhanced migration of GFP-RCPWT 
expressing cells. We hypothesise that the reduced levels 
of N-cadherin, and concomitant increase of E-cadherin, at 
the surface of RCP-depleted cells is a major contributor to 
their reduced motility. 
The levels of E- and N- cadherin are normally 
tightly regulated and alterations in the balance of these 
two cadherins can lead to cells undergoing epithelial-
mesenchymal transition (EMT). EMT is a process in 
which epithelial cells lose their characteristic polarity, 
disassemble cell-cell junctions and become more motile. 
This process is important for normal development, but also 
during tumour metastasis. One of the key features of EMT 
is cadherin switching in which cells shift from expressing 
E-cadherin to expressing N-cadherin. Cancer cells often 
recapitulate this switch, resulting in an aggressive tumour 
cell that can leave the primary tumour and metastasize 
[36]. The cadherin switch in A549 cells treated with the 
TGFβ1 ligand, to induce EMT, was dampened when 
RCP was knocked down. This data suggests that RCP 
can directly influence EMT. EMT is also associated with 
morphological changes, in which cells transform from 
a typical epithelial ‘cobblestone’ appearance to a more 
loosely connected elongated appearance with prominent 
actin stress fibres. Induction of RCP overexpression in 
the A549 stable cell lines was sufficient to trigger these 
cells to adopt a mesenchymal morphology. These results 
indicate that RCP overexpression can promote EMT, and 
that depletion of RCP results in cells assuming a more 
epithelial and less motile phenotype.
RCP regulates N-cadherin endosomal recycling
Cadherin expression in epithelial tumours can be 
regulated at both transcriptional and post-transcriptional 
levels. RT-qPCR revealed that RCP knockdown did 
not consistently alter E- or N- cadherin mRNA levels, 
suggesting that RCP regulates cadherin expression at the 
post-transcriptional level. E- and N- cadherin undergo 
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Figure 6: The endosomal recycling inhibitor primaquine mimics RCP knockdown. (A) A549 cell monolayers were wounded 
and allowed to recover for 18 hours in media supplemented with the indicated concentrations of primaquine. The histogram depicts the 
distance migrated (*p < 0.05, ***p < 0.001; n = 4). (B) Protein levels of N-cadherin (black) and E-cadherin (white) in lysates from cells 
used in the wound healing assays above (*p < 0.05, ***p < 0.001; n = 4). (C) Timeline of the N-cadherin recycling assay used in C, D and 
E. (D) A549 cells treated as indicated in C, were fixed and N-cadherin at the cell surface was labelled with an antibody that recognised the 
N-cadherin ectodomain. (E) N-cadherin recycling assay in A549 cells allowed to recover in the presence or absence of 200 µM PMQ (*p < 
0.05, **p < 0.01; n = 4). (F) E-cadherin recycling assay in A549 cells allowed to recover in the presence or absence of 200 µM PMQ (**p < 
0.01; n = 4).
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proteolytic processing at the plasma membrane by the 
sequential action of a number of proteases including 
ADAM10, presenilin-1, and caspase-3. The ADAM10 
metalloproteinase cleaves the ectodomain of both E- and 
N- cadherin at the plasma membrane, releasing it into the 
extracellular environment in a process called “shedding”. 
The intracellular domains of the cadherins are further 
cleaved by presenilin-1 and caspase-3. Linford et al. 
have proposed that Rab14 plays a role in the transport of 
ADAM10 to the plasma membrane, thereby regulating 
the processing of N-cadherin [13]. However, our results 
indicate that RCP does not play a role in N-cadherin 
shedding as we do not observe an increase of N-cadherin 
C-terminal fragments in RCP-depleted cells, and an 
ADAM10 inhibitor does not restore the levels of full-
length N-cadherin. Indeed, while we did observe that 
depletion of Rab14 inhibits cell motility (Supplementary 
Figure S6B, S6C); we could not observe an effect of 
Rab14 depletion on the level of N- or E- cadherin in A549 
cell lysates (Supplementary Figure S6D–S6F).
To investigate whether RCP-depletion led to 
increased lysosomal or proteasomal degradation of 
N-cadherin we treated siRNA transfected cells with 
ammonium chloride or lactacystin for the final 24 hours 
of the transfection. Ammonium chloride is a lysosomal 
inhibitor and lactacystin is a selective proteasome 
inhibitor. Lactacystin had no effect, but ammonium 
chloride treatment resulted in a 36–61% recovery of 
N-cadherin levels. This suggests that RCP-depletion leads 
to increased lysosomal degradation of N-cadherin and we 
propose a model in which RCP regulates the recycling 
of endocytosed N-cadherin to the plasma membrane 
(Figure 8A). In the absence of RCP, N-cadherin cannot 
be recycled and is diverted to the degradative pathway 
(Figure 8B).
The increase of E-cadherin protein levels in RCP-
depleted cells may be due to a surplus of p120 catenin, 
since N-cadherin is downregulated in these cells. p120 
catenin associates with both cadherins and binds to the 
juxtamembrane domain of E-cadherin masking a dileucine 
motif, thus preventing its endocytosis and leading to its 
stabilisation at the plasma membrane [37]. Depletion 
of RCP strongly inhibited the recycling of N-cadherin 
to the cell surface in a quantitative cadherin trafficking 
Figure 7: N-cadherin is continuously internalised and recycled in A549 cells. (A) An A549 cell monolayer was treated +/– 300 
µM PMQ for 1 hour at 37ºC. The cells were fixed, quenched and N-cadherin at the plasma membrane was immunolabelled with an antibody 
that recognises its extracellular domain. Bar, 10 µm. (B) A549 cells, treated as above, were fixed, quenched and permeablised prior to co-
staining with antibodies to N-cadherin (green) and RCP (red). Bar, 10 µm.  The histogram depicts the degree of colocalisation between RCP 
and N-cadherin (*p < 0.05; n = 3).
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assay. N-cadherin has recently been found to undergo 
polarized recycling from the cell rear to the leading edge 
in migrating primary rat astrocytes [38]. The authors of 
this study demonstrate that N-cadherin undergoes clathrin-
mediated endocytosis at the cell rear and is transported to 
the leading edge, in a process that takes 30–40 minutes. We 
found that the endosomal recycling inhibitor, primaquine, 
also significantly inhibited N-cadherin recycling in A549 
cells. Furthermore, primaquine inhibited the migration of 
A549 cells and led to a reduction in N-cadherin, but not 
E-cadherin, protein levels. These results mimic the effects 
of RCP depletion and further confirm the importance 
of the endosomal recycling pathway in the transport of 
N-cadherin to the plasma membrane. 
Interestingly, while this manuscript was under 
revision Boulay et al. reported that RCP plays a role in 
Figure 8: RCP regulates the endosomal recycling of N-cadherin. (A) N-cadherin endocytosed from the cell rear undergoes RCP-
dependent polarised recycling to the leading edge. (B) In the absence of RCP, N-cadherin is diverted to lysosomes where it is degraded. 
EE–Early Endosome; ERC–Endosomal Recycling Compartment; MVB–Multivesicular Body.
Oncotarget104729www.impactjournals.com/oncotarget
E-cadherin trafficking [39]. The authors reported that 
loss of RCP leads to the downregulation of E-cadherin 
and increased metastatic potential of ErbB2 positive 
breast tumours. This is the reverse of our observations 
in A549 lung adenocarcinoma cells, i.e. that loss of RCP 
leads to an increase of E-cadherin and a corresponding 
decrease in their metastatic potential. However, as the 
authors of this study point out, the ability of RCP to act 
as an oncogene or tumour suppressor is likely to be highly 
dependent on tumour type. Indeed, Rab25 which interacts 
directly with RCP has been found to act as an oncogene in 
ovarian cancer and certain breast cancers and as a tumour 
suppressor in colon and intestinal carcinomas [3].
The results presented here provide further evidence 
for the importance of the endosomal recycling pathway 
in epithelial cell carcinogenesis, by driving the transport 
of adhesion proteins and receptor tyrosine kinases to 
the leading edge of migrating tumour cells and helps to 
explain how aberrant expression of regulators of this 
pathway can lead to the increased aggressiveness of a wide 
range of cancers. 
MATERIALS AND METHODS
Reagents and antibodies
General laboratory chemicals were from Sigma-
Aldrich. Exherin (ADH-1) was from AdooQ Bioscience. 
The following antibodies were used; α-tubulin (mouse 
B-5-1-2; Sigma-Aldrich), GM130 (mouse clone 35; 
BD Biosciences), E-cadherin (mouse clone 36; BD 
Biosciences), E-cadherin (goat S-17; Santa Cruz), 
N-cadherin (mouse clone 32; BD Biosciences), 
N-cadherin (sheep #AF6426; R&D Systems), N-cadherin 
(rabbit #ab18203; Abcam), Rab14 (rabbit #R0656; Sigma) 
and RCP (chicken #GW21574A; Sigma). Secondary 
antibodies raised in donkey to chicken, goat, mouse, 
rabbit, and sheep conjugated to IRDye 700, IRDye 
800CW, Alexa-488, and Cy3 were from Molecular Probes, 
Jackson ImmunoResearch, LI-COR, and Rockland. Texas 
Red-Phalloidin was from Molecular Probes.
Cell culture and transfections
A549 cells were obtained from the ECACC and 
cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% foetal bovine serum (Sigma), 
100 U/ml penicillin/streptomycin, and 2 mM glutamine at 
37oC in 5% CO2. For siRNA transfections Lipofectamine 
RNAiMax (Invitrogen) was used according to the 
manufacturer’s instructions. RNAi duplexes were obtained 
from Sigma (siFLuc 5′- CUUACGCUGAGUACUUCGA 
-3′; siRCP#3 5′- CAAACAGAAGGAAACGAUA -3′; 
siRCP#4 5′- CCAUCAUCAGUGAGAACUU -3′; and 
siRCP#5 5′- CCUCGCUUCUGGAGUGUUA -3′). The 
stable cell lines were generated by transfecting A549 
cells with pEGFP-C3, pEGFP-C3 RCPWT, and pEGFP-C3 
RCPI621E [31] using TurboFect (Thermo Fisher Scientific). 
Transfectants were selected with 800 µg/ml G418 for 
approximately two weeks and stable colonies were 
isolated using cloning rings. Fusion protein expression 
was induced by supplementing the culture medium with 
5 mM sodium butyrate for 24 hours.
Cell migration assays
For the wound healing assays, A549 cells in 24-well 
plates were scratched with a 200 μl pipette tip, washed 
twice with PBS and fresh culture medium was added. 
Brightfield images were recorded (0 hours) and the cells 
were returned to 37oC for 18 hours, after which another 
brightfield image was acquired. The distance that the 
wound front had migrated was calculated using ImageJ 
(NIH). The cells were subsequently lysed in 100 μl RIPA 
Buffer (10 mM Tris, pH 7.4; 1 mM EDTA; 5 μM EGTA; 
1% TX-100; 0.1% sodium deoxycholate; 0.1% SDS; 
140 mM NaCl) supplemented with protease inhibitor 
cocktail (Roche), in order to assess knockdown efficiency 
by Western blot. 
For the live wound healing assays, A549 cells 
in 4-well plates were transfected for 72 hours with the 
indicated siRNA duplex. The monolayer was wounded 
with a 200 μl pipette tip, washed twice with PBS and 
fresh culture medium, supplemented with 25 mM Hepes 
pH7.4, was added. Plates were placed in an Olympus 
IX51 inverted microscope in a temperature controlled 
environmental chamber (Solent Scientific), set at 37oC. The 
plates were allowed to equilibrate for 30 minutes, following 
which brightfield time-lapse movies were recorded with a 
10 × 0.3 NA air objective at 1 frame every 10 minutes for 
over 10 hours. Greater than 50 cells per condition were 
tracked using the Manual Tracking plugin of ImageJ and 
trajectories, velocities and directionalities were calculated 
using the Chemotaxis and Migration Tool Version 2 (Ibidi).
For the migration assay, knockdown cells or 
cells stably expressing the GFP-fusion proteins, were 
detached with trypsin, counted and 30,000 cells were 
seeded per well (in duplicate) in serum-free medium into 
the upper chamber of a CIM-16 Transwell plate (Acea 
Biosciences). Serum-containing medium was used as 
the chemoattractant in the lower chamber. The plate was 
placed in an xCelligence RTCA DP Analyzer located in a 
tissue culture incubator and Cell Index (CI) measurements 
were recorded every 30 minutes for 72 hours. 
The invasion assay was performed exactly as above, 
with the exception that the A549 cells were seeded on 
top of a layer of Matrigel (BD Biosciences) in the upper 
chamber.
Endothelial monolayer invasion assay
The intravasation assay was performed as described 
previously [40]. In brief, 2.5 × 104 HUVEC cells, in 
100 µl EGM-2 medium (Lonza), were seeded in each 
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well of an E-16 plate (Acea Biosciences) that had been 
pre-coated with 0.1% gelatin. The plate was placed in the 
xCelligence RTCA DP Analyzer and the endothelial cells 
were allowed to form a monolayer. Once the impedance 
readings reached a plateau (~ 18–21 hours), A549 cells 
were detached with 5 mM EDTA/PBS, washed twice with 
PBS, and 10,000 cells in 100 µl complete DMEM was 
added to each well. Impedance readings were recorded 
every 10 minutes for 7 hours.
Immunofluorescence microscopy
Cells were seeded on 10 mm glass coverslips, fixed 
with 4% paraformaldehyde, quenched with 50 mM NH4Cl, 
and blocked/permeablised with 0.05% saponin/0.2% 
bovine serum albumin. Cells were incubated with the 
indicated primary antibodies in the blocking solution. The 
secondary antibodies used were Cy3-conjugated donkey 
anti-rabbit from Jackson ImmunoResearch Laboratories 
(West Grove, PA) and Alexa488–conjugated goat anti-
chicken from Molecular Probes. The cells were washed 
extensively with phosphate-buffered saline (PBS) between 
antibody incubations, and the coverslips were mounted 
in Mowiol. To immunolabel cell surface cadherin the 
cells were blocked with 1% BSA/PBS and all antibody 
incubations were performed in 1% BSA/PBS. 
Images were acquired on a Zeiss LSM510 confocal 
microscope (Carl Zeiss, Jena, Germany). Colocalisation 
coefficients were calculated using the colocalisation 
module of the Zeiss Zen 2009 software.
Cadherin recycling assays
A549 cells were seeded in 96-well plates and 
allowed to form monolayers. The cells were induced to 
internalise their adherens junctions by incubating with 
2.5 mM EDTA in 100 µl serum-free medium for 1 hour. 
The cells were then washed twice with PBS and 100 µl 
fresh complete medium was added and cell-cell junctions 
were allowed to re-form for 0, 30, 60, and 90 minutes at 
37oC. The cells were fixed at each time-point by addition 
of 100 µl 8% paraformaldehyde, directly into the culture 
medium.  After quenching with 50 mM NH4Cl, the cells 
were blocked with 1% BSA/PBS for 1 hour at room-
temperature (RT). E- and N- cadherin at the cell surface 
was labelled with goat anti-E cadherin (Santa Cruz) and 
sheep anti-N cadherin (R&D Systems) antibodies in 1% 
BSA/PBS, respectively.  The wells were extensively 
washed with PBS and incubated with donkey anti-goat 
or anti-sheep conjugated to IRDye 800 CW plus DRAQ5 
(Abcam) in 1% BSA/PBS for 1 hour at RT. The cells were 
extensively washed with PBS and scanned on an Odyssey 
Infrared Imager (Licor). The cadherin signal in each well 
was normalised against the DRAQ5 far-red fluorescent 
DNA dye signal.
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